Trevi Therapeutics, Inc. (TRVI)
10.30
-0.12
(-1.15%)
USD |
NASDAQ |
Jan 21, 16:00
10.31
+0.01
(+0.10%)
After-Hours: 20:00
Trevi Therapeutics EPS Diluted (Quarterly): -0.0813 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Arbutus Biopharma Corp. | -0.0404 |
| Bristol Myers Squibb Co. | 1.079 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.80M |
| Total Expenses (Quarterly) | 11.80M |
| Enterprise Value | 1.127B |
| Earnings Yield | -3.60% |
| Normalized Earnings Yield | -3.605 |